KRTL BioTech

ValueAct CEO Jeff Ubben to step down: Financial Times

ValueAct CEO Jeff Ubben to step down: Financial Times

ValueAct Capital Partners LP's founder Jeff Ubben is stepping down as chief executive officer and will be replaced by the activist hedge fund's president, Mason Morfit, the Financial Times reported on Wednesday.